The Matt Harvey News Isn’t Good
Three seasons ago, Matt Harvey was one of the best pitchers in all of major-league baseball. Over 26 starts, his 2.00 FIP was the best among all starters. His 2.27 ERA placed behind only Clayton Kershaw and Jose Fernandez’s marks by that measure. Despite a relative deficit of innings, Harvey’s 6.5 WAR was third among pitchers behind only Clayton Kershaw and Adam Wainwright.
The reason for that low-ish innings total? A partially torn UCL that ended Harvey’s season in August and ultimately required Tommy John surgery. Rehab kept Harvey off the mound for the entire 2014 campaign, as well, but he came back strong in 2015, posting a 2.71 ERA (82 ERA-) and 3.05 FIP (80 FIP-), and proved instrumental in getting the New York Mets into the World Series.
The 2016 campaign has been an up-and-down one for Harvey — and will feature much more down than up going forward, as reports indicate that the right-hander will undergo surgery for thoracic outlet syndrome. For the Mets, the loss of Harvey is a threat to their postseason odds. For Harvey himself, it’s a threat to his career.
On May 20, Eno Sarris wondered, What’s Wrong with Matt Harvey? His conclusion: that maybe the slider wasn’t quite as good as it had been, by movement or location, and that a little bit of work on that pitch might right the ship. For a time after that, Harvey appeared to have gotten things in order. In five starts beginning May 30, Harvey went at least six innings in every start, striking out 25 against five walks with a 2.25 ERA and 2.08 FIP. His strikeouts were down a bit from last year in that stretch (25% to 21%), but his walks also decreased (7% to 4%).